Interferon Therapy of Relapsed and Refractory Hodgkin's Disease
Depressed In Vitro T Cell Responses Concomitant with Augmented Interleukin-2 Responses by Lymphocytes from Cancer Patients Following In Vivo Treatment with Interleukin-2
In Vivo Effects of Cytokines on Development of Natural Killer Cells and Antitumor Activity in Lethally Irradiated Bone Marrow Transplanted Recipients
Antiviral Activity of the Novel Immune Modulator 7-Thia-8-Oxoguanosine
Macrophage Activation by Muramyl Dipeptide Bound to Neoglycoproteins and Glycosylated Polymers
Therapeutic Efficacy of Recombinant Tumor Necrosis Factor α in an Experimental Model of Human Prostatic Carcinoma
Synergistic Actions of Picibanil (OK-432) on Recombinant Interleukin-2 Induction of Tumor-Infiltrating Lymphocyte Expansion, Cytotoxicity, and Phenotypic Differentiation
Biological and Clinical Effects of the Oral Immunomodulator 3,6-Bis(2-piperidinoethoxy)acridine Trihydrochloride in Patients with Malignancy
A Pilot Study of Intralymphatic Interleukin-2. I. Cytotoxic and Surface Marker Changes of Peripheral Blood Lymphocytes
A Pilot Study of Intralymphatic Interleukin-2. II. Clinical and Biological Effects
Modulation of Human Alveolar Macrophage Tumoricidal Activity by Recombinant Macrophage Colony-Stimulating Factor
Heterogeneity of Cell Surface Structures Involved in Cytotoxicity Mediated by Lymphokine Activated Killer Cells
Muramyl Peptides and Polyinosinic—Polycytodylic Acid Given to Mice Prior to Influenza Virus Challenge Reduces Pulmonary Disease and Mortality
Human Spleen and Peripheral Blood Lymphocytes Activated by Interleukin-2 Have Similar Phenotypic and Functional Characteristics
Interferon-α-n1 and Continuous Infusion Vinblastine for Treatment of Advanced Renal Cell Carcinoma
Announcement